An important role for mitochondrial antiviral signaling protein in the kaposi's sarcoma-associated herpesvirus life cycle

Journal of Virology

Volumn 88, Issue 10, 2014, Pages 5778-5787

  West, John A ^a,b   Wicks, Megan ^a,b   Gregory, Sean M ^a,b   Chugh, Pauline ^a,b   Jacobs, Sarah R ^a,b   Zhang, Zhigang ^a,b   Host, Kurtis M ^a,b   Dittmer, Dirk P ^a,b   Damania, Blossom ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; GENETIC TRANSCRIPTION; HUMAN HERPESVIRUS 8; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; RETINOICACID INDUCIBLE GENE 1; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS INDUCTION; VIRUS INHIBITION; VIRUS LATENCY; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; DEAD-BOX RNA HELICASES; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; SIGNAL TRANSDUCTION; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 84899106416     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03226-13     Document Type: Article

References (43)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869. http://dx.doi .org/10.1126/science.7997879.
2. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191. http://dx .doi.org/10.1056/NEJM199505043321802.
3. Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, Tschachler E, Colombini S, Ensoli B, Sturzl M. 1997. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71:7963-7968.
4. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, O'Leary JJ. 1995. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1:1274-1278. http://dx.doi.org/10.1038/nm1295-1274.
5. Monini P, Colombini S, Sturzl M, Goletti D, Cafaro A, Sgadari C, Butto S, Franco M, Leone P, Fais S, Melucci-Vigo G, Chiozzini C, Carlini F, Ascherl G, Cornali E, Zietz C, Ramazzotti E, Ensoli F, Andreoni M, Pezzotti P, Rezza G, Yarchoan R, Gallo RC, Ensoli B. 1999. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 93:4044-4058.
6. Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR. 1997. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276:1851-1854. http://dx.doi .org/10.1126/science.276.5320.1851.
7. Wu W, Vieira J, Fiore N, Banerjee P, Sieburg M, Rochford R, Harrington W, Jr, Feuer G. 2006. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood 108:141-151. http://dx.doi.org/10 .1182/blood-2005-04-1697.
8. Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, Chandran B. 2004. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcomaassociated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78: 3601-3620. http://dx.doi.org/10.1128/JVI.78.7.3601-3620.2004.
9. Lee HR, Brulois K, Wong L, Jung JU. 2012. Modulation of immune system by kaposi's sarcoma-associated herpesvirus: lessons from viral evasion strategies. Front. Microbiol. 3:44. http://dx.doi.org/10.3389/fmicb .2012.00044.
10. Creagh EM, O'Neill LA. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27: 352-357. http://dx.doi.org/10.1016/j.it.2006.06.003.
11. Ye Z, Ting JP. 2008. NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr. Opin. Immunol. 20:3-9. http://dx .doi.org/10.1016/j.coi.2008.01.003.
12. Gregory SM, West JA, Dillon PJ, Hilscher C, Dittmer DP, Damania B. 2009. Toll-like receptor signaling controls reactivation of KSHV from latency. Proc. Natl. Acad. Sci. U. S. A. 106:11725-11730. http://dx.doi.org /10.1073/pnas.0905316106.
13. West J, Damania B. 2008. Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus. J. Virol. 82:5440-5449. http://dx.doi.org /10.1128/JVI.02590-07.
14. West JA, Gregory SM, Sivaraman V, Su L, Damania B. 2011. Activation of plasmacytoid dendritic cells by Kaposi's sarcoma-associated herpesvirus. J. Virol. 85:895-904. http://dx.doi.org/10.1128/JVI.01007-10.
15. Gregory SM, Davis BK, West JA, Taxman DJ, Matsuzawa S, Reed JC, Ting JP, Damania B. 2011. Discovery of a viral NLR homolog that inhibits the inflammasome. Science 331:330-334. http://dx.doi.org/10.1126/science .1199478.
16. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G. 2006. 5=-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997. http: //dx.doi.org/10.1126/science.1132505.
17. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C. 2006. RIG-I-mediated antiviral responses to singlestranded RNA bearing 5'-phosphates. Science 314:997-1001. http://dx .doi.org/10.1126/science.1132998.
18. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496. http://dx.doi.org/10.1038/ni921.
19. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801. http://dx.doi.org/10.1016/j.cell.2006.02.015.
20. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920. http://dx.doi.org/10.1038/nature05732.
21. Inn KS, Lee SH, Rathbun JY, Wong LY, Toth Z, Machida K, Ou JH, Jung JU. 2011. Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J. Virol. 85: 10899-10904. http://dx.doi.org/10.1128/JVI.00690-11.
22. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. 2009. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10:1065-1072. http://dx.doi.org/10.1038/ni.1779.
23. Cheng G, Zhong J, Chung J, Chisari FV. 2007. Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc. Natl. Acad. Sci. U. S. A. 104:9035-9040. http://dx .doi.org/10.1073/pnas.0703285104.
24. Chiu YH, Macmillan JB, Chen ZJ. 2009. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138:576-591. http://dx.doi.org/10.1016/j.cell.2009.06.015.
25. Rasmussen SB, Jensen SB, Nielsen C, Quartin E, Kato H, Chen ZJ, Silverman RH, Akira S, Paludan SR. 2009. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible genelike receptors, which synergize to induce type I interferon production. J. Gen. Virol. 90:74-78. http://dx.doi.org/10.1099/vir.0.005389-0.
26. Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K. 2006. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 25:4207-4214. http://dx.doi.org/10.1038/sj .emboj.7601314.
27. Samanta M, Iwakiri D, Takada K. 2008. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 27:4150-4160. http://dx.doi.org/10.1038/onc.2008.75.
28. Vieira J, O'Hearn PM. 2004. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325:225-240. http://dx.doi.org/10.1016/j.virol.2004.03.049.
29. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J. Virol. Methods 174:12-21. http: //dx.doi.org/10.1016/j.jviromet.2011.03.012.
30. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU. 2012. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J. Virol. 86:9708-9720. http://dx.doi.org/10.1128/JVI.01019-12.
31. Dittmer DP. 2011. Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy. mBio 2:e00138-00111. http://dx.doi.org/10.1128/mBio.00138-11.
32. Papin J, Vahrson W, Hines-Boykin R, Dittmer DP. 2005. Real-time quantitative PCR analysis of viral transcription. Methods Mol. Biol. 292: 449-480. http://dx.doi.org/10.1385/1-59259-848-X:449.
33. Dittmer DP. 2003. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by realtime PCR arrays. Cancer Res. 63:2010-2015.
34. Rozen S, Skaletsky H. 2000. Primer3 on theWWWfor general users and for biologist programmers. Methods Mol. Biol. 132:365-386. http://dx .doi.org/10.1385/1-59259-192-2:365.
35. Lock EF, Ziemiecke R, Marron J, Dittmer DP. 2010. Efficiency clustering for low-density microarrays and its application to QPCR. BMC Bioinformatics 11:386. http://dx.doi.org/10.1186/1471-2105-11-386.
36. Chugh P, Tamburro K, Dittmer DP. 3 December 2010. Profiling of pre-micro RNAs and microRNAs using quantitative real-time PCR (qPCR) arrays. J. Vis Exp.. http://dx.doi.org/10.3791/2210.
37. Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Chandran B. 2009. Kaposi's sarcoma-associated herpesvirus utilizes an actin polymer-ization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells. J. Virol. 83:4895-4911. http://dx.doi.org/10.1128/JVI.02498-08.
38. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS. 2002. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298:1432-1435. http://dx.doi.org/10.1126/science.1074883.
39. Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449:819 -826. http://dx.doi.org/10.1038 /nature06246.
40. Paludan SR, Bowie AG, Horan KA, Fitzgerald KA. 2011. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11:143-154. http://dx.doi.org/10.1038/nri2937.
41. Chandriani S, Xu Y, Ganem D. 2010. The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. J. Virol. 84:7934-7942. http://dx.doi.org/10.1128/JVI.00645-10.
42. Dresang LR, Teuton JR, Feng H, Jacobs JM, Camp DG, II, Purvine SO, Gritsenko MA, Li Z, Smith RD, Sugden B, Moore PS, Chang Y. 2011. Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes.BMC Genomics 12:625. http://dx.doi.org/10.1186/1471-2164-12-625.
43. Malathi K, Dong B, Gale M, Jr, Silverman RH. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819. http://dx.doi.org/10.1038/nature06042.